kongre.net
Welcome to kongre.net

Speaker

Aparajita Chourasia

Senior VP, Drug Development & Biology, BioTheryx

Aparajita Chourasia, Senior VP, Drug Development & Biology at BioTheryx, spoke at 9th TPD & Induced Proximity Summit (Boston, United States of America, 26–29 Oct 2026) in the session “BTX-9341, a First-in-Class, Potent & Selective CDK4/6 Degrader, for the Treatment of Advanced/Metastatic HR+/HER2- Breast Cancer Post-CDK4/6 Inhibitor Therapy – Latest from the Clinic”.

Conferences
1
Keynotes
0
Upcoming
0

Past appearances

More speakers at 9th TPD & Induced Proximity Summit

  • Stuart Schreiber

    Professor, Harvard Medical School

  • Randy Teel

    President & Chief Executive Officer, Arvinas, Inc.

  • Carla Bauer

    Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co

  • Alyn Davies

    Associate Director, Medicinal Chemistry, AstraZeneca

  • Adam Gilbert

    Science Partner, Flagship Pioneering

  • Jason Kantor

    Chief Business Officer, Nurix Therapeutics, Inc.

See all 61 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Aparajita Chourasia, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].